SCHEMBL2212356

SCHEMBL2212356

Cc1ccc(-n2nc(-c3ccco3)cc2N)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 7/20 0.76
PTGS2 P35354 1/20 0.74
MEN1 O00255 5/20 0.64
KMT2A Q03164 5/20 0.64
RECQL P46063 4/20 0.64
KDM4E B2RXH2 3/20 0.64
CTDSP1 Q9GZU7 2/20 0.64
MAPT P10636 6/20 0.61
NPC1 O15118 5/20 0.61
RAB9A P51151 5/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
ALDH1A1 P00352 6/20 0.58
POLB P06746 4/20 0.58
L3MBTL1 Q9Y468 4/20 0.57
LMNA P02545 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3169074 0.99 PTGS1 (0.74) PTGS1PTGS2MEN1KMT2ARECQL
SCHEMBL13757326 0.81 PTGS1 (0.58) PTGS1PTGS2MEN1KMT2ARECQL
SCHEMBL13532154 0.77 NPC1 (0.61) PTGS1PTGS2MEN1KMT2AMAPT
Hydrochloric Acid SCHEMBL3182589 0.76 NPC1 (0.60) PTGS1PTGS2MEN1KMT2AMAPT
SCHEMBL6582639 0.73 RAB9A (1.00) MEN1KMT2AKDM4EMAPTNPC1
SCHEMBL1143708 0.73 RAB9A (1.00) PTGS1MEN1KMT2AKDM4EMAPT
SCHEMBL25407314 0.72 PTGS1 (0.56) PTGS1PTGS2MEN1KMT2AKDM4E
SCHEMBL4263645 0.71 RAB9A (0.61) PTGS1MEN1KMT2AKDM4EMAPT
SCHEMBL224624 0.71 CYP1A2 (0.72) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL28906662 0.71 RAB9A (1.00) PTGS1MEN1KMT2AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1866302-B1 PYRAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2011-07-27 EP disclosed
US-7767696-B2 Antitumor agents; tyrosine inhbitor; controllling kinase signal transduction MERCK PATENT GMBH (DE) 2010-08-03 US disclosed
US-20100016319-A1 ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF TORAY INDUSTRIES, INC. A CORPORATION OF JAPAN (JP) 2010-01-21 US disclosed
US-20100016319-A1 ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF TORAY INDUSTRIES, INC. A CORPORATION OF JAPAN (JP) 2010-01-21 US disclosed
CN-101316841-A Arylmethylene urea derivative and use thereof TORAY INDUSTRIES (JP) 2008-12-03 CN disclosed
EP-1970375-A1 ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF TORAY INDUSTRIES, INC. (JP) 2008-09-17 EP disclosed
US-20080207699-A1 Pyrazole Derivatives MERCK PATENT GMBH (DE) 2008-08-28 US disclosed
EP-1866302-A1 PYRAZOLE DERIVATIVES Merck Patent GmbH (DE) 2007-12-19 EP disclosed
WO-2006105844-A1 PYRAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2006-10-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207699-A1 Pyrazole Derivatives TIE1, FER, RAF1 PTGS1 1799/4885PTGS2 1022/4885MEN1 377/4885
US-20100016319-A1 ARYLMETHYLENE UREA DERIVATIVE AND USE THEREOF UROD, UTS2R, SLC14A1 PTGS1 319/4885PTGS2 261/4885MEN1 3856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.